Table 2.

Estimated progression of coronary atherosclerosis, as change in MCAD or %ST, per 50 % increment in total plasma AR among postmenopausal women (n 182), Estrogen Replacement and Atherosclerosis trial, USA

	Effect on outcome per 50 % increment in total plasma AR
	Change in mean MCAD			Change in mean %ST
	Estimate	95 % CI	P value	Estimate	95 % CI	P value
Model 1*	−0·0035	−0·0171, 0·0101	0·61	0·14	−0·36, 0·64	0·59
Model 2†	−0·0021	−0·0161, 0·0118	0·76	0·09	−0·42, 0·61	0·73

MCAD, minimum coronary artery diameter; %ST, percentage diameter stenosis; AR, alkylresorcinols.

^*Adjusted for age, race, BMI, treatment group, follow-up years, clinic and the corresponding baseline measure.

^†Adjusted as for model 1, plus current smoking, physical activity and education level.